Alpine Immune Sciences, Inc. (ALPN): Price and Financial Metrics

Alpine Immune Sciences, Inc. (ALPN): $64.97

0.01 (+0.02%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add ALPN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#269 of 360

in industry

ALPN Price/Volume Stats

Current price $64.97 52-week high $65.00
Prev. close $64.96 52-week low $8.33
Day low $64.97 Volume 4,288,300
Day high $65.00 Avg. volume 1,917,072
50-day MA $52.49 Dividend yield N/A
200-day MA $26.27 Market Cap 4.46B

ALPN Stock Price Chart Interactive Chart >


Alpine Immune Sciences, Inc. (ALPN) Company Bio


Alpine Immune Sciences, Inc. is focused on developing novel protein‐based immunotherapies using its proprietary Variant Ig Domain vIgD platform technology. The vIgD platform is designed to interact with multiple targets, including many present in the immune synapse. Alpine’s vIgDs are developed using a process known as directed evolution, which can potentially produce proteins capable of either enhancing or diminishing an immune response and thereby may potentially apply therapeutically to both oncology and inflammatory diseases. The company formed following a July, 2017 merger with Nivalis Therapeutics.


ALPN Latest News Stream


Event/Time News Detail
Loading, please wait...

ALPN Latest Social Stream


Loading social stream, please wait...

View Full ALPN Social Stream

ALPN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 371.82%
3-year 430.37%
5-year 2,220.36%
YTD 240.87%
2023 159.32%
2022 -46.93%
2021 9.92%
2020 228.13%
2019 4.35%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!